tykhr
sign in
free sign up
Organogenesis Holdings Inc
Drug Manufacturers - Specialty & Generic
Healthcare
ORGO
126 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
4.77
52 week high
6.21
high
4.89
52 week low
0.00
low
4.74
growth
68.20 %
previous Close
4.72
P/E ratio
market cap
573 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
44.45 %
eps surprise
-14.98 %
net profit margin
0.00 %
24.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top